Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of repeated applications of tenofovir gel on mucosal mediators of immunity and intrinsic antimicrobial activity of cervicovaginal secretions in women at low risk for HIV-1 infection.

X
Trial Profile

Effect of repeated applications of tenofovir gel on mucosal mediators of immunity and intrinsic antimicrobial activity of cervicovaginal secretions in women at low risk for HIV-1 infection.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 May 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 12 May 2010 Actual patient number (30) added as reported by ClinicalTrials.gov.
    • 12 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top